Don’t Be Rash: Introducing Andrew C. Krakowski, MD, and the Pediatric Dermatology Journey

This introductory episode of Don’t Be Rash with Andrew C. Krakowski, MD, opens a broader series focused on contemporary issues in pediatric dermatology. Instead of focusing on a single disease or therapy, the discussion looks at pediatric dermatology as a whole—how the subspecialty has developed, how treatment has evolved over time, and the ongoing questions that continue to shape everyday clinical practice.

At its core, pediatric dermatology is defined by its scope: caring for patients from birth through adolescence, where skin disease is shaped not only by biology but also by growth, development, and family context. As Krakowski reflects in this introduction, that complexity is part of what makes the subspecialty distinct. It also explains why focused training and mentorship play such a central role in shaping how clinicians enter and grow within the field.

Over the past 2 decades, pediatric dermatology has moved through several clear inflection points: the adoption of propranolol for infantile hemangiomas, the arrival of biologic therapy for atopic dermatitis such as dupilumab, and the expanding use of highly effective biologics in psoriasis that are redefining treatment goals toward near-complete or complete clearance. These shifts are not just incremental—they have changed expectations for outcomes in many chronic inflammatory conditions.

Another theme Don’t Be Rash will discuss is how clinicians actually integrate innovation into practice. Krakowski highlights that adoption of new therapies is rarely immediate or purely guideline-driven. Instead, it emerges through shared clinical experience, mentorship, conference dialogue, and accumulated real-world reassurance about safety and efficacy—particularly when treating children.

The series will also explore emerging clinical questions that do not yet have definitive answers. One example raised here is ongoing research into microbial reservoirs in atopic dermatitis, including early observations suggesting that patient-use emollient containers may contribute to Staphylococcus aureus colonization. While still preliminary, this kind of inquiry reflects the field’s continued effort to refine even long-standing assumptions about disease mechanisms and everyday clinical practice.

Ultimately, this series is intended as a clinician-focused forum: a place to connect landmark advances with practical decision-making, and to explore how pediatric dermatology continues to change in real time through evidence, experience, and shared discussion.

Don’t Be Rash is produced in collaboration with the Society for Pediatric Dermatology. For more information on the society, its programs, and resources, check out their website.

Have a topic you think we should talk about? Email us at [email protected] to join the conversation!